Development and testing of a new disposable sterile device for labelling white blood cells

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 56, Issue 4, 2012, Pages 400-408

  Signore, A ^a,b   Glaudemans, A W J M ^b   Malviya, G ^a,b   Lazzeri, E ^c   Prandini, N ^d   Viglietti, A L ^e   De Vries, E F J ^b   Dierckx, R A J O ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF PISA   (Italy)

^d Universitaria Ferrara ^*  (Italy)

^e S CROCE E CARLE HOSPITAL   (Italy)

Author keywords

Infection; Leukocytes; Radionuclide imaging

Indexed keywords

DEXTRAN; HEPARIN; LIPOPOLYSACCHARIDE;

ARTICLE; BIOCOMPATIBILITY; BLOOD SAMPLING; CELL FUNCTION; CELL ISOLATION; CELL LABELING; CELL VIABILITY; CHEMOTAXIS; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; GOOD MANUFACTURING PRACTICE; HUMAN; HUMAN CELL; IMAGING SYSTEM; INTERMETHOD COMPARISON; ISOLATION AND PURIFICATION; ISOTOPE LABELING; LABORATORY DEVICE; LABORATORY PERSONNEL; LEUKOCYTE; LEUKOKIT; MICROBIAL CONTAMINATION; PLASMA; RISK ASSESSMENT; RISK REDUCTION; SCINTIGRAPHY;

CELL SEPARATION; CELL TRACKING; CELLS, CULTURED; DISPOSABLE EQUIPMENT; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; HUMANS; ISOTOPE LABELING; LEUKOCYTE COUNT; LEUKOCYTES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; STERILIZATION; TECHNETIUM TC 99M EXAMETAZIME;

EID: 84869849347     PISSN: 18244785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Annovazzi A, Bagni B, Burroni L, D'Alessandria C, Signore A. Nuclear medicine imaging of inflammatory/infective disorders of the abdomen. Nucl Med Commun 2005;26:657-64. (Pubitemid 40910871)
2. Capriotti G, Chianelli M, Signore A. Nuclear medicine imaging of diabetic foot infection: results of meta-analysis. Nucl Med Commun 2006;27:757-64. (Pubitemid 44401242)
3. Cascini GL, De Palma D, Matteucci F, Biggi A, Rambaldi PF, Signore A et al. Fever of unknown origin, infection of subcutaneous devices, brain abscesses and endocarditis. Nucl Med Commun 2006;27:213-22. (Pubitemid 44391808)
4. Signore A, Chianelli M, D'Alessandria C, Annovazzi A. Receptor targeting agents for imaging inflammation/infection: where are we now? Q J Nucl Med Mol Imaging 2006;50:236-42.
5. Signore A, Soroa VA, De Vries EFJ. Radiobelled white blood cells or FDG for imaging on inflammation and infection? Q J Nucl Med Mol Imaging 2009;53:23-5.
6. Prandini N, Feggi L, Massari L. Diagnosis of bone infections using 99mTc-HMPAO labelled leukocytes. Nucl Med Commun 2002;23:1245-8.
7. Prandini N, Lazzeri E, Rossi B, Erba P, Parisella MG, Signore A. Nuclear medicine imaging of bone infections. Nucl Med Commun 2006;27:633-44. (Pubitemid 44305304)
8. Roca M, Martin-Comin J, Becker W, Bernardo-Filho M, Gutfilen B, Moisan A et al. A consensus protocol for white blood cells labelling with technetium-99m hexamethylpropylene amine oxime. International Society of Radiolabeled Blood Elements (ISORBE). Eur J Nucl Med. 1998;25:797-9. (Pubitemid 28377045)
9. Bleeker-Rovers CP, Boerman OC, Rennen HJ, Corstens FH, Oyen WJ. Radiolabeled compounds in diagnosis of infectious and inflammatory disease. Curr Pharm Des 2004;10:2935-50. (Pubitemid 39220313)
10. Palestro CJ, Love C, Bhargava KK. Labeled leukocyte imaging: current status and future directions. Q J Nucl Med Mol Imaging 2009;53:105-23.
11. Liebers V, Stubel H, Duser M, Bruning T, Raulf-Heimsoth M. Standardization of whole blood assay for determination of pyrogenic activity in organic dust samples. Int J Hyg Environ Health 2009;212:547-56.